Nov 15, 2017
The JP Morgan Healthcare Conference, or “JPM”, is the healthcare conference of the year. Companies from all over the world convene in San Francisco to setup meetings with investors, prospective partners, service providers, etc. and lay the groundwork for much of the...
Nov 9, 2017
It is that time of year again when the interventional cardiology and vascular communities reflect on the recent Transcatheter Cardiovascular Therapeutics (TCT) meeting which took place in Denver and finished late last week. We take pause to remember that TCT is one...
Nov 2, 2017
Besides calling the Ghostbusters, how does one catch a ghost? That is the question asked by most life science companies trying to raise capital from family offices, which we define as a non-institutional investor capable of investing $1M or more into an individual...
Oct 25, 2017
For many years, the fundraising environment for MedTech companies has been exceedingly difficult. Venture firms that were historically active in MedTech shifted their investment allocations to other areas of life sciences and capital became constrained. New entrants...
Oct 11, 2017
Each quarter Locust Walk experts compile key statistics and trends on strategic transactions and financings. Our Q3 report uses the latest data to analyze current trends in the life science deal landscape. In this report you can find an overview and analysis of:...